Adicet Bio(us:ACET)
0.7350
-2.65%
Updated on 2025-04-02
Open:0.7700
Close:0.7350
High:0.8191
Low:0.7350
Prev Close:0.7550
Volume:347458.00
Turnover:268987.75
Turnover Ratio:0.42%
Shares:82.69M
MarketCap:60.77M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 3 | 4691 | 0.01% | 0 | 1 | 0 |
| 2024-03-31 | 107 | 74719825 | 90.93% | 32 | 40 | 22 |
| 2023-12-31 | 92 | 33367571 | 77.11% | 9 | 28 | 41 |
| 2023-09-30 | 104 | 35246416 | 81.76% | 13 | 30 | 43 |
| 2023-06-30 | 122 | 36707951 | 85.24% | 18 | 26 | 62 |
| 2023-03-31 | 124 | 38969001 | 90.72% | 26 | 26 | 53 |
| 2022-12-31 | 124 | 42033481 | 97.86% | 25 | 31 | 53 |
| 2022-09-30 | 119 | 41518244 | 97.03% | 20 | 43 | 40 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Orbimed Advisors Llc | 11447140 | 13.93% | 3125000 | 37.55% |
| 2024-03-31 | Ra Capital Management, L.P. | 7541000 | 9.18% | 7541000 | |
| 2024-03-31 | Tang Capital Management Llc | 6407400 | 7.80% | 5531048 | 631.14% |
| 2024-03-31 | Balyasny Asset Management L.P. | 6181671 | 7.52% | 6181671 | |
| 2024-03-31 | Rtw Investments, Lp | 4134631 | 5.03% | 0 | |
| 2024-03-31 | Millennium Management Llc | 4106170 | 5.00% | 2784583 | 210.70% |
| 2024-03-31 | Morgan Stanley | 4067305 | 4.95% | 1268496 | 45.32% |
| 2024-03-31 | Goldman Sachs Group Inc | 4005587 | 4.87% | 3976974 | 13899.19% |
| 2024-03-31 | Blackrock Inc. | 3373232 | 4.11% | 1190557 | 54.55% |
| 2024-03-31 | Vanguard Group Inc | 3126578 | 3.81% | 1441503 | 85.55% |
About
Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.
Address:131 Dartmouth Street,3rd floor
Website:http://www.adicetbio.com
Market Movers